A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence

NCT ID: NCT01899313

Last Updated: 2014-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This Phase I behavior therapy development study seeks to improve treatment outcomes for methamphetamine (MA)-dependent subjects by developing a novel cognitive behavioral therapy- (CBT-) based short message service (SMS) text messaging intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amphetamine-Related Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CBT- based SMS text messaging intervention

cognitive behavioral therapy- (CBT-) based short message service (SMS) text messaging intervention

Group Type EXPERIMENTAL

CBT- based SMS text messaging intervention

Intervention Type BEHAVIORAL

CBT group therapy

Intervention Type BEHAVIORAL

Placebo Texts

Placebo texts will be given instead of interventional texts

Group Type PLACEBO_COMPARATOR

CBT group therapy

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CBT- based SMS text messaging intervention

Intervention Type BEHAVIORAL

CBT group therapy

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cognitive Behavioral Group Therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* English-speaking adults ≥ 18 years who are seeking treatment for MA addiction.
* Own a cellular phone with SMS text messaging capability and have an unlimited text messaging plan.
* Available to attend CBT therapy groups.
* Agreeable to conditions of the study and signed an informed consent form.

Exclusion Criteria

* Projected to be unavailable \> 12 hours/day to read and send text messages.
* Any medical or psychosocial condition that would preclude safe, useful, or consistent participation,
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

California Pacific Medical Center Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gantt Galloway, PharmD

Senior Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gantt Galloway, PharmD

Role: PRINCIPAL_INVESTIGATOR

California Pacific Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New Leaf Treatment Center

Lafayette, California, United States

Site Status RECRUITING

Addiction & Pharmacology Research Laboratory

San Francisco, California, United States

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kathleen Garrison

Role: CONTACT

415-600-3126

Reshmi Pal

Role: CONTACT

415-600-1652

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kathleen Garrison

Role: primary

415-600-1652

Kathleen Garrison

Role: primary

415-600-1652

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012.119-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Studying Amphetamine Withdrawal in Humans
NCT01215929 COMPLETED PHASE2